No Data
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Denali Capital Acquisition Pushes Merger Deadline With Extra Funding
Scilex Holding Company Announces Change in Record Date for Its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., Its Wholly Owned Subsidiary From January 28,...
Scilex Holding Ends Sales Agreement With Brokers
Scilex Ends Sales Agreement With B. Riley, Cantor Fitzgerald, H.C. Wainwright With No Penalty; During The Term Of The Agreement Sold 2.76M Shares For $2.69M
Express News | Scilex Holding Co - Terminates Sales Agreement With B. Riley, Cantor Fitzgerald, H.c. Wainwright Effective March 5
!
